XML 52 R17.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 11 - Summary of Stock Options
12 Months Ended
Dec. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]

11.      Summary of Stock Options


Stock Option Plans


The Company has issued equity awards in the form of stock options from three employee benefit plans. The plans include the PLC 2005 Stock Incentive Plan (the “2005 Plan”), the Viveve Amended and Restated 2006 Stock Plan (the “2006 Plan”) and the PLC 2013 Stock Option and Incentive Plan (the “2013 Plan”).


The 2005 Plan was adopted by PLC's Board of Directors and approved by its stockholders. 22,095 shares of common stock remain reserved for issuance under the 2005 Plan. The Company does not intend to grant further awards from the 2005 Plan, however, it will continue to administer the 2005 Plan until all outstanding awards are exercised, expire, terminate or are forfeited. There are currently outstanding stock option awards issued from the 2005 Plan covering a total of 22,095 shares of the Company’s common stock. The weighted average exercise price of the outstanding stock options is $12.83 per share and the weighted average remaining contractual term is 5.30 years.


The 2006 Plan was adopted by the Board of Directors of Viveve and was terminated in conjunction with the Merger. Outstanding stock option awards have been assumed by the Company and will continue to be administered in accordance with the terms of the 2006 Plan until such awards are exercised, expire, terminate or are forfeited. There are currently outstanding stock option awards issued from the 2006 Plan covering a total of 322,069 shares of the Company’s common stock and no shares available for future awards. The weighted average exercise price of the outstanding stock options is $1.54 per share and the weighted average remaining contractual term is 7.82 years. Additionally, prior to the Merger, the Board of Directors voted to accelerate the vesting of all unvested options that were outstanding as of the date of the Merger such that all options would be immediately vested and exercisable by the holders. Furthermore, at the Merger, outstanding options to purchase shares of Viveve, Inc. common stock issued from the 2006 Plan were converted into options to purchase shares of the Company’s Common Stock (rounded down to the nearest whole share). The number of shares of the Company’s common stock into which the 2006 Plan options were converted was determined by multiplying the number of shares covered by each 2006 Plan option by the exchange ratio of 0.0080497. The exercise price of each 2006 Plan option was determined by dividing the exercise price of each 2006 Plan option immediately prior to the Merger by the exchange ratio of 0.0080497 (rounded up to the nearest cent).


The 2013 Plan was also adopted by PLC's Board of Directors and approved by its stockholders. The 2013 Plan is administered by the Compensation Committee of the Company’s Board of Directors (the “Administrator”). Under the 2013 Plan, the Company may grant to eligible partcipants equity awards which may take the form of stock options (both incentive stock options and non-qualified stock options), stock appreciation rights, restricted, deferred or unrestricted stock awards, performance based awards or dividend equivalent rights. Awards may be granted to officers, employees, non-employee Directors (as defined in the 2013 Plan) and other key persons (including consultants and prospective employees). The term of any stock option award may not exceed 10 years and may be subject to vesting conditions, as determined by the Administrator. Options granted generally vest over four years. Incentive stock options may be granted only to employees of the Company or any subsidiary that is a “subsidiary corporation” within the meaning of Section 424(f) of the Internal Revenue Code. The exercise price of any stock option award cannot be less than the fair market value of the Company’s common stock, provided, however, that an incentive stock option granted to an employee who owns more than 10% of the Company’s outstanding voting power must have an exercise price of no less than 110% of the fair market value of the Company’s common stock and a term that does not exceed five years. There are currently outstanding stock option awards issued from the 2013 Plan covering a total of 1,947,619 shares of the Company’s common stock and there remain reserved for future awards 841,739 shares of the Company’s common stock. The weighted average exercise price of the outstanding stock options is $0.80 per share, and the remaining contractual term is 9.62 years. Concurrent with the Merger, the stockholders approved an amendment to the 2013 Plan to increase the number of shares reserved under the 2013 Plan from 113,826 to 3,111,587.


Activity under the 2005 Plan, the 2006 Plan and the 2013 Plan is as follows:


    Year Ended December 31,   
    2014      2013   
   

Number

of

Shares

   

Weighted Average Exercise Price

   

Weighted Average Remaining Contractual Term (years)

   

Aggregate

Intrinsic

Value

(in thousands)

   

Number

of

Shares

   

Weighted Average Exercise Price

   

Weighted Average Remaining Contractual Term (years)

   

Aggregate

Intrinsic

Value

(in thousands)

 

Options outstanding, beginning of year

    363,413     $ 1.24       8.80               360,531     $ 1.24       9.74          

Options granted

    1,901,476     $ 0.60                       95,581     $ 1.24                  

Options assumed from PLC

    68,238     $ 10.24                       -     $ -                  

Options exercised

    (160 )   $ 0.12                       -     $ -                  

Options canceled

    (41,184 )   $ 1.83                       (92,699 )   $ 1.24                  

Options outstanding, end of year

    2,291,783     $ 1.02       9.32     $ -       363,413     $ 1.24       8.80     $ -  
                                                                 

Vested and exercisable and expected to vest, end of year

    2,099,687     $ 1.06       9.29     $ -       348,865     $ 1.24       8.80     $ -  
                                                                 

Vested and exercisable, end of year

    519,901     $ 2.45       7.89     $ -       120,955     $ 2.48       8.60     $ -  

As of December 31, 2014, the Company had 841,739 shares available for grant.


The aggregate intrinsic value reflects the difference between the exercise price of the underlying stock options and the Company’s closing share price as of December 31, 2014.


The options outstanding and exercisable as of December 31, 2014 are as follows (in thousands except share and per share data):


          Options Outstanding     Options Exercisable  
                          Weighted                  
          Number     Weighted     Average     Number     Weighted  
          Outstanding     Average     Remaining     Exercisable     Average  

Range of 

    as of     Exercise     Contractual     as of     Exercise  

Exercise Prices 

    December 31, 2014     Price     Term (Years)     December 31, 2014     Price  
$0.60       1,901,476     $ 0.60       9.64       129,594     $ 0.60  
$1.24       312,373     $ 1.24       7.90       312,373     $ 1.24  
$7.00 - $9.00       58,603     $ 8.64       7.46       58,603     $ 8.64  
$12.00 - $18.63       19,081     $ 15.29       6.54       19,081     $ 15.29  
$37.00       250     $ 37.00       3.47       250     $ 37.00  
            2,291,783     $ 1.02       9.32       519,901     $ 2.45  

Stock-Based Compensation


During the year ended December 31, 2014, the Company granted stock options to employees to purchase 1,901,476 shares of common stock with a weighted-average grant date fair value of $0.32 per share. Stock-based compensation expense recognized during the year ended December 31, 2014 and 2013 was $184,000 and $87,000, respectively. As of December 31, 2014, the total unrecognized compensation cost in connection with unvested stock options was approximately $496,000. These costs are expected to be recognized over a period of approximately 3.73 years. The aggregate intrinsic value of options outstanding as of December 31, 2014 and 2013 was $0. The aggregate intrinsic value of options exercised during the years ended December 31, 2014 and 2013 was $0. The total estimated grant date fair value of options vested during the years ended December 31, 2014 and 2013 was $44,000 and $140,000, respectively.


The Company estimated the fair value of stock options using the Black-Scholes option pricing model. The fair value of employee stock options is being amortized on a straight-line basis over the requisite service period of the awards. The fair value of employee stock options granted was estimated using the following assumptions:


    Year Ended   
   

Decenber 31,

 
   

2014

   

2013

 

Expected term (in years)

    5       5  

Average volatility

    61 %     68 %

Risk-free interest rate

    1.80 %     0.84 %

Dividend yield

    0 %     0 %

Option-pricing models require the input of various subjective assumptions, including the option’s expected life and the price volatility of the underlying stock. The expected stock price volatility is based on analysis of the Company’s stock price history over a period commensurate with the expected term of the options, trading volume of comparable companies’ stock, look-back volatilities and Company specific events that affected volatility in a prior period. The expected term of employee stock options represents the weighted average period the stock options are expected to remain outstanding and is based on the history of exercises and cancellations on all past option grants made by the Company, the contractual term, the vesting period and the expected remaining term of the outstanding options. The risk-free interest rate is based on the U.S. Treasury interest rates whose term is consistent with the expected life of the stock options. No dividend yield is included as the Company has not issued any dividends and does not anticipate issuing any dividends in the future.


The following table shows stock-based compensation expense included in the consolidated statements of operations for the years ended December 31, 2014 and 2013 (in thousands):


    Year Ended  
    Year Ended December 31,  
    2014     2013  
                 

Research and development

  $ 5     $ -  

Selling, general and administrative

    179       87  

Total

  $ 184     $ 87  

Prior to the merger, the Company’s Board of Directors approved the acceleration of vesting of all unvested stock options that were outstanding under the 2006 Plan as of the date of the merger. For the year ended December 31, 2014, the Company recorded additional stock-based compensation expense (primarily in selling, general and administrative expenses in the consolidated statement of operations for the year ended December 31, 2014) of approximately $103,000 associated with the acceleration of vesting of approximately 140,000 affected stock options.